Natixis Advisors LLC Purchases 263 Shares of Silicon Laboratories Inc. (NASDAQ:SLAB)

Natixis Advisors LLC grew its position in shares of Silicon Laboratories Inc. (NASDAQ:SLAB) by 2.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,313 shares of the semiconductor company’s stock after acquiring an additional 263 shares during the quarter. Natixis Advisors LLC’s holdings in Silicon Laboratories were worth $1,530,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of SLAB. Raymond James Financial Inc. bought a new stake in Silicon Laboratories during the 4th quarter valued at $14,252,000. Arizona State Retirement System grew its holdings in shares of Silicon Laboratories by 1.8% during the fourth quarter. Arizona State Retirement System now owns 9,360 shares of the semiconductor company’s stock valued at $1,163,000 after buying an additional 167 shares during the last quarter. Franklin Resources Inc. increased its position in shares of Silicon Laboratories by 1.9% during the third quarter. Franklin Resources Inc. now owns 231,889 shares of the semiconductor company’s stock worth $27,001,000 after acquiring an additional 4,278 shares in the last quarter. Point72 Asset Management L.P. bought a new position in Silicon Laboratories in the 3rd quarter valued at about $7,408,000. Finally, Intech Investment Management LLC boosted its stake in Silicon Laboratories by 82.9% during the 3rd quarter. Intech Investment Management LLC now owns 12,837 shares of the semiconductor company’s stock valued at $1,484,000 after purchasing an additional 5,818 shares during the last quarter.

Analysts Set New Price Targets

SLAB has been the subject of several analyst reports. Needham & Company LLC reissued a “buy” rating and issued a $150.00 price objective on shares of Silicon Laboratories in a research note on Wednesday, March 12th. Benchmark reissued a “buy” rating and issued a $160.00 price target on shares of Silicon Laboratories in a research report on Wednesday, March 12th. StockNews.com raised shares of Silicon Laboratories from a “sell” rating to a “hold” rating in a report on Tuesday, March 18th. Stifel Nicolaus increased their target price on shares of Silicon Laboratories from $135.00 to $145.00 and gave the company a “buy” rating in a report on Monday, January 6th. Finally, Susquehanna began coverage on shares of Silicon Laboratories in a report on Tuesday, December 17th. They set a “neutral” rating and a $130.00 price target on the stock. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $136.20.

Insiders Place Their Bets

In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of the stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total transaction of $281,540.00. Following the sale, the director now owns 32,115 shares in the company, valued at $4,520,828.55. This represents a 5.86 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Navdeep S. Sooch sold 2,360 shares of Silicon Laboratories stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total value of $351,640.00. Following the completion of the transaction, the director now owns 400,567 shares of the company’s stock, valued at approximately $59,684,483. This trade represents a 0.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,360 shares of company stock worth $782,610 over the last quarter. 1.72% of the stock is currently owned by company insiders.

Silicon Laboratories Trading Up 1.4 %

NASDAQ:SLAB opened at $125.29 on Tuesday. Silicon Laboratories Inc. has a 12 month low of $94.00 and a 12 month high of $160.00. The firm’s 50 day moving average is $137.87 and its 200 day moving average is $123.40. The stock has a market capitalization of $4.07 billion, a PE ratio of -21.09 and a beta of 1.15.

Silicon Laboratories (NASDAQ:SLAB) last issued its earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.11). The firm had revenue of $166.25 million for the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The business’s revenue was up 91.4% on a year-over-year basis. During the same period in the previous year, the company posted ($1.19) earnings per share. Research analysts predict that Silicon Laboratories Inc. will post -0.97 earnings per share for the current year.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.